Perret Jason, Van Craenenbroeck Mélanie, Langer Ingrid, Vertongen Pascale, Gregoire Françoise, Robberecht Patrick, Waelbroeck Magali
Department of Biochemistry and Nutrition, School of Medicine, Université Libre de Bruxelles, Bât G/E, CP 611, 808 Route de Lennik, B-1070 Bruxelles, Belgium.
Biochem J. 2002 Mar 1;362(Pt 2):389-94. doi: 10.1042/0264-6021:3620389.
Receptor recognition by the Asp(3) residues of vasoactive intestinal peptide and secretin requires the presence of a lysine residue close to the second transmembrane helix (TM2)/first extracellular loop junction and an ionic bond with an arginine residue in TM2. We tested whether the glucagon Gln(3) residue recognizes the equivalent positions in its receptor. Our data revealed that the binding and functional properties of the wild-type glucagon receptor and the K188R mutant were not significantly different, whereas all agonists had markedly lower potencies and affinities at the I195K mutated receptor. In contrast, glucagon was less potent and the Asp(3)-, Asn(3)- and Glu(3)-glucagon mutants were more potent and efficient at the double-mutated K188R/I195K receptor. Furthermore, these alterations were selective for position 3 of glucagon, as shown by the functional properties of the mutant Glu(9)- and Lys(15)-glucagon. Our results suggest that although the Gln(3) residue of glucagon did not interact with the equivalent binding pocket as the Asp(3) residue of vasoactive intestinal peptide or secretin, the Asp(3)-glucagon analogue was able to interact with position 188 of the K188R/I195K glucagon receptor. Nevertheless, the Gln(3) side chain of glucagon probably binds very close to this region in the wild-type receptor.
血管活性肠肽和促胰液素的天冬氨酸(Asp)3残基对受体的识别需要靠近第二个跨膜螺旋(TM2)/第一个细胞外环连接点处存在一个赖氨酸残基,以及与TM2中的一个精氨酸残基形成离子键。我们测试了胰高血糖素的谷氨酰胺(Gln)3残基是否识别其受体中的等效位置。我们的数据显示,野生型胰高血糖素受体和K188R突变体的结合和功能特性没有显著差异,而所有激动剂在I195K突变受体上的效力和亲和力均明显较低。相反,胰高血糖素效力较低,而天冬氨酸(Asp)3-、天冬酰胺(Asn)3-和谷氨酸(Glu)3-胰高血糖素突变体在双突变K188R/I195K受体上效力更高且更有效。此外,这些改变对胰高血糖素的3位具有选择性,如突变型谷氨酸(Glu)9-和赖氨酸(Lys)15-胰高血糖素的功能特性所示。我们的结果表明,尽管胰高血糖素的谷氨酰胺(Gln)3残基不像血管活性肠肽或促胰液素的天冬氨酸(Asp)3残基那样与等效结合口袋相互作用,但天冬氨酸(Asp)3-胰高血糖素类似物能够与K188R/I195K胰高血糖素受体的188位相互作用。然而,胰高血糖素的谷氨酰胺(Gln)3侧链可能在野生型受体中与该区域非常接近地结合。